Interpace Biosciences, Inc. (IDXG) stock
IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)
Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –
Interpace Biosciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Interpace Biosciences's EV/EBITDA was 29.3× on Oct 19, 2026, against 0.7× a year earlier. Over the last 2 years it ranged from 0.2× to 44.6×, with a median of 1.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 29.3× | +28.5 |
| 2025 | Dec 31, 2025 | 0.8× | −0.5 |
| 2024 | Dec 31, 2024 | 1.3× | – |
See a number that looks wrong?